There’s been a growing interest in this product ever since it was introduced. And it’s no wonder. LATISSE® is the first and only FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller and darker.
Discover the LATISSE® difference.
LATISSE® solution is a growth treatment for hypotrichosis (inadequate or not enough eyelashes). In fact, it’s the only FDA-approved treatment clinically proven to grow lashes. And it’s the only lash growth product of its kind available by prescription. So you’ll need to talk to your doctor to see if it’s right for you.
LATISSE® grows lashes longer, fuller and darker.
LATISSE® solution is a once-nightly treatment you apply topically to the base of your upper eyelashes, as instructed by your doctor. Then, gradually, the results come in. You may start to see more length in as little as 4 weeks and you should achieve full growth in 16 weeks. It’s not an illusion of growth. It’s real lash growth.
Real unretouched lashes of women who've used LATISSE®.
Individual results may vary. The lashes displayed are unretouched, without mascara. If you stop using LATISSE®, your eyelashes are expected to return to their previous appearance over several weeks to months. Results may vary from eye to eye. There may be differences in eyelash length, thickness, fullness, pigmentation (darkness), number of eyelash hairs or the direction of eyelashes. If you experience any of these variations in your lashes, they will usually go away once you stop using LATISSE®.
How LATISSE® works.
LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.
The history behind LATISSE®.
LATISSE® was created by Allergan. In 2001, Allergan developed a medicated eye drop to treat elevated intraocular pressure. Many patients using this medication also began to grow longer, fuller and darker lashes as a side effect. This led Allergan to study the medication's active ingredient, bimatoprost, specifically for growing lashes. After a clinical trial, LATISSE® was approved by the FDA in December of 2008.
LATISSE® (bimatoprost ophthalmic solution) 0.03% Important Information
• LATISSE® is a prescription treatment for hypotrichosis (inadequate or not enough lashes) to grow eyelashes longer, fuller, darker.
• Important Safety Information: If you use/used prescription products for eye pressure problems, use LATISSE® under doctor care. LATISSE® may cause increased brown pigmentation of the colored part of the eye which is likely permanent. Eyelid skin darkening may occur and may be reversible. Only apply at the base of upper lashes. DO NOT APPLY to lower lid. Hair may grow on skin that LATISSE® frequently touches. If you have eye problems/surgery, consult your doctor about use of LATISSE®. Common side effects are itchy and red eyes. If discontinued, lashes gradually return to previous appearance.